San Diego, CA 7/27/10—Ilumina has announced that it completed the purchase of Helixis on April 30 for $70 million in cash and up to $35 million in contingent consideration. Helixis is the developer of a high-performance, low-cost real-time PCR system. Illumina will begin selling the system, the Eco, in August for a list price of […]
Quincy, IL 7/1/10—Gardner Denver, a provider of fluid transfer equipment, has acquired ILMVAC GmbH for an undisclosed amount. ILMVAC supplies vacuum pumps, systems and accessories for R&D labs and industrial applications. In 2009, ILMVAC had revenues of $11.6 million. “ILMVAC has technical expertise in applying existing vacuum technology for lab applications tailored, in particular, to […]
Tokyo, Japan 6/30/10—Hitachi High-Technologies has announced that Tokyo Customs has accepted its petition to deny the Japanese import of FEI’s Strata 400 scan ning/transmission electron microscope and Helios NanoLab 400S scanning electron microscope/focused ion beam (FIB) system. Hitachi High-Technologies charges that the systems violate its Japanese Patent Number 4100450. The company stated that it had […]
Darmstadt, Germany 7/15/10—Merck KGaA has announced the closing of its acquisition of Millipore for $7.0 billion (see IBO 3/15/10). The new company will be named Merck Millipore and will consist of three business units: Bioscience, Lab Solutions and Process Solutions. Headquartered in Billerica, Massachusetts, with 10,000 employees, Merck Millipore had 2009 pro forma revenues of […]
Männedorf, Switzerland 7/15/10; Poway, CA 7/15/10—Tecan has announced an agreement to sell its REMP AG subsidiary and related assets to NEXUS Biosystems, a supplier of sample management systems, for CHF 12 million ($11 million = CHF 1.06 = $1) and additional deferred payments of $4.4–$7.7 million. Based in Oberdiessbach, Switzerland, with 120 employees, REMP provides […]
Santa Clara, CA 7/7/10—Affymetrix has announced that it expects second-quarter revenues to be $71–$72 million, compared to its earlier guidance of $80–$82 million (see IBO 5/15/10). Product revenue is forecast to be approximately $65–$66 million, including $4–$5 million in instrument sales and consumables sales of $60–$61 million. The company stated three primary reasons for the […]
Heidelberg, Germany and Lexington, MA 6/23/10—Microfluidics firm febit has announced a restructuring in order to focus on blood-based microRNA biomarker discovery, including collaborations and services for clinical researchers. The company’s workforce will be reduced by 60%. President and CEO Cord F. Staehler has resigned and was replaced by Hartmut Voss, PhD, and Jochen Kohlhaas, who […]
Baltimore, MD 6/30/10—Celsis In Vitro (Celsis IVT) a provider of specialized in vitro products, has filed suit against Invitrogen, a Life Technologies company, in US District Court in the Northern District of Illinois. The complaint alleges that processes and methods performed by Invitrogen’s CellzDirect subsidiary infringe Celsis IVT’s US Patent No. 7,604,929 (Novel Cellular Compositions […]
Washington, DC 6/10/10—The FDA has notified Illumina that its Infinium HumanHap550 array when used as part of deCODE Genetics and 23andMe’s genetic information businesses is considered a device under section 201(h) of the Federal Food, Drug, and Cosmetic Act. In a letter to Illumina, the FDA stated that the array requires premarket approval for clinical […]
Santa Clara, CA and San Diego, CA 6/30/10—Accelrys stockholders and stockholders in Symyx Technologies have approved the companies’ merger (see IBO 4/15/10). Each companies’ stockholders will own half of the combined company. Leading up to the shareholders vote on June 30, Symyx fielded repeated counter offers from Certara, which is owned by Vector Capital (see […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
